The Precision Peptide Company Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| XU0.F | NAII | UCFI | NUC.AX | FTLF | NOU.AX | |
|---|---|---|---|---|---|---|
| Market cap | 8.93M | 6.89M | 287.81M | 9.57M | 76.82M | 33.25M |
| P/E (TTM) | — | — | 29.0 | — | 13.2 | — |
| Forward P/E | — | — | — | -6.1 | 6.3 | 0.8 |
| Price/book | 5.0 | 0.1 | 12.3 | 1.6 | 1.6 | -0.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +39.67% | −62.20% | 0.00% | −60.00% | −56.37% | −7.69% |
| Today | −5.03% | +3.77% | −0.02% | +1.67% | +3.68% | 0.00% |
The closest companies by business and industry (Packaged Foods). Prices may be delayed up to 20 min.
Latest news
All XU0.F news ›The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
The order follows the Company’s September 8, 2026 news release, “The Precision Peptide Company Advances Thymosin Alpha-1 Patch into Formal U.S. Testing,” regarding the development of its Thymosin Alpha-1 transdermal patch. The order is for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
- cantechletter.com1
- newsfilecorp.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.